medmix AG
SIX:MEDX.SW
9.62 (CHF) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 486.6 | 477.1 | 457.3 | 351.3 | 420.7 | 454 |
| Cost of Revenue
| 328.9 | 301.7 | 276.1 | 230.2 | 258.3 | 281.4 |
| Gross Profit
| 157.7 | 175.4 | 181.2 | 121.1 | 162.4 | 172.6 |
| Gross Profit Ratio
| 0.324 | 0.368 | 0.396 | 0.345 | 0.386 | 0.38 |
| Reseach & Development Expenses
| 25.7 | 23.6 | 23 | 20.2 | 22.9 | 22.5 |
| General & Administrative Expenses
| 119 | 103 | 95.6 | 81.3 | 86.2 | 85.2 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 119 | 103 | 95.6 | 81.3 | 86.2 | 85.2 |
| Other Expenses
| 0.9 | -2.6 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 143.4 | 125.9 | 118.3 | 100.7 | 108.6 | 105.6 |
| Operating Income
| 16 | 19.6 | 59.9 | 18.1 | 38.2 | 62.9 |
| Operating Income Ratio
| 0.033 | 0.041 | 0.131 | 0.052 | 0.091 | 0.139 |
| Total Other Income Expenses Net
| -13.1 | -7.4 | -8.6 | -7.6 | -7.3 | -6.8 |
| Income Before Tax
| 2.9 | 12.2 | 51.3 | 10.5 | 30.9 | 56.1 |
| Income Before Tax Ratio
| 0.006 | 0.026 | 0.112 | 0.03 | 0.073 | 0.124 |
| Income Tax Expense
| 2.2 | 0.6 | 7.3 | 0.8 | 5.7 | 3.8 |
| Net Income
| 0.3 | 11.6 | 44 | 9.6 | 25.2 | 52.2 |
| Net Income Ratio
| 0.001 | 0.024 | 0.096 | 0.027 | 0.06 | 0.115 |
| EPS
| 0.007 | 0.28 | 1.07 | 0.23 | 0.61 | 1.27 |
| EPS Diluted
| 0.007 | 0.28 | 1.07 | 0.23 | 0.61 | 1.27 |
| EBITDA
| 69.7 | 96.2 | 110.9 | 64.8 | 96.4 | 111.5 |
| EBITDA Ratio
| 0.143 | 0.202 | 0.243 | 0.184 | 0.229 | 0.246 |